Che Xu
Impact in
- Cell Biology top 1%
- Endoplasmic Reticulum Stress and Disease
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in ⓘ
-
- Histone Deacetylase Inhibitors Research 2
- Oncology 5
- Cytokine Signaling Pathways and Interactions 2
- Peptidase Inhibition and Analysis 2
- Co-authors
- Qiang You (8 shared papers)Ting Zhao (8 shared papers)Jinshun Pan (8 shared papers)Xianmin Mu (8 shared papers)Biao Geng (7 shared papers)Chao Wang (5 shared papers)Jiajia Shen (4 shared papers)Jing Yang (5 shared papers)
- Journals
- Oncotarget (2 papers)Phytomedicine (1 paper)Journal of Clinical Oncology (1 paper)American Journal of Physiology-Lung Cellular and Molecular Physiology (1 paper)Cell Cycle (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Che Xu
13 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Cell Biology 1.1k
- Cancer Research 366
- Geriatrics and Gerontology 84
- Immunology 449
- Epidemiology 693
Countries citing papers authored by Che Xu
This map shows the geographic impact of Che Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Che Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Che Xu more than expected).
Fields of papers citing papers by Che Xu
This network shows the impact of papers produced by Che Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Che Xu. The network helps show where Che Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Che Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Endoplasmic reticulum stress: cell life and death decisions Hit paper breakdown → | 2005 | 1941 |
| 2 | 2018 | 349 | |
| 3 | 2018 | 109 | |
| 4 | 2017 | 96 | |
| 5 | 2018 | 87 | |
| 6 | 2017 | 40 | |
| 7 | 2019 | 38 | |
| 8 | 2011 | 31 | |
| 9 | 2021 | 15 | |
| 10 | 2017 | 10 | |
| 11 | 2017 | 4 | |
| 12 | 2025 | 1 | |
| 13 | The effects of recombinant RA538 and antisense c-myc adenovirus on tumor cells and the molecular mechanism concerned. | 2000 | 1 |
| 14 | 2021 | 0 |
About Che Xu
Che Xu is a scholar working on Molecular Biology, Oncology, Surgery, Immunology and Epidemiology, having authored 14 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (2 papers), Transplantation: Methods and Outcomes (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Immune cells in cancer (2 papers), Organ Transplantation Techniques and Outcomes (2 papers), Peptidase Inhibition and Analysis (2 papers), Pancreatic function and diabetes (1 paper) and Invertebrate Immune Response Mechanisms (1 paper). The work is most often cited by research in Cell Biology (1.1k citations), Cancer Research (366 citations), Geriatrics and Gerontology (84 citations), Immunology (449 citations) and Epidemiology (693 citations). Che Xu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Qiang You, Ting Zhao, Jinshun Pan, Xianmin Mu, Biao Geng, Chao Wang, Jiajia Shen, Jing Yang, Hu Shi and Wei Shi. Their work appears in journals such as Oncotarget, Phytomedicine, Journal of Clinical Oncology, American Journal of Physiology-Lung Cellular and Molecular Physiology and Cell Cycle.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.